SFX by Ex Libris Inc.

Title:	Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics
Source:	Cellular and Molecular Life Sciences [1420-682X] Delolme, Frédéric yr:2014

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gipson, Debbie S. "Complete Remission in the Nephrotic Syndrome Study Network." Clinical journal of the American Society of Nephrology 11.1 (2015): 81-9.
description	2.	Zhang, X. "Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry." American journal of translational research 6.3 (2014): 267-280.
description	3.	Francis, Jean M. "Membranous Nephropathy: A Journey From Bench to Bedside." American journal of kidney diseases 68.1 (2016): 138-147.
description	4.	Venning, Michael C. "Long-term outcomes of persistent disease and relapse in primary membranous nephropathy." Nephrology, Dialysis, Transplantation (2016).
description	5.	Korkmaz, E. "ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS." Journal of the American Society of Nephrology 27.1 (2015): 63-68.
description	6.	Koenders, Marije I. "Novel therapeutic targets in rheumatoid arthritis." Trends in pharmacological sciences 36.4 (2015): 189-195.
description	7.	Scott, Nichollas E. "Comparative proteomics and glycoproteomics reveal increased n-linked glycosylation and relaxed sequon specificity in campylobacter jejuni nctc11168 o." Journal of proteome research 13.11 (2014): 5136-5150.
description	8.	Zhang, P. "iTRAQ-Based Proteomics Reveals Novel Members Involved in Pathogen Challenge in Sea Cucumber Apostichopus japonicus." PLoS ONE 9.6 (2014).
description	9.	Lv, J. "Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis." CMAJ : Canadian Medical Association Journal 185.11 (2013): 949-957.
description	10.	Hofstra, Julia M. "Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?" Kidney international 89.5 (2016): 981-983.
description	11.	Radhakrishnan, A. "Crystal structure of the Campylobacterjejuni CmeC outer membrane channel." Protein science 23.7 (2014): 954-61.
description	12.	Upadhyay, A. "Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier." Annals of Internal Medicine 154.8 (2011): 541-8.
description	13.	Cattran, Daniel C. "Membranous nephropathy: integrating basic science into improved clinical management." Kidney international 91.3 (2017): 566-574.
description	14.	Hildebrandt, F. "Genetics of Kidney Diseases." Seminars in nephrology 36.6 (2016): 472-474.
description	15.	Kalantari, S. "A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis." Mammalian Genome 27.3-4 (2016): 158-167.
description	16.	Hoxha, E. "Membranous Nephropathy: The Journey Continues …." EBioMedicine (2015): 374-5.
description	17.	Fervenza, Fernando C C. "A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)." The Nephron journals 130.3 (2015): 159-68.
description	18.	Merali, Z. "Neuroproteome changes after ischemia/reperfusion injury and tissue plasminogen activator administration in rats: a quantitative iTRAQ proteomics study." PLoS ONE 9.5 (2014).
description	19.	McInnes, I. "Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases." Pharmacological reviews 67.2 (2015): 280-309.
description	20.	Thanh, Nguyen M. "A transcriptomic analysis of striped catfish (Pangasianodon hypophthalmus) in response to salinity adaptation: De novo assembly, gene annotation and marker discovery." Comparative biochemistry and physiology - Part D: genomics and proteomics 10 (2014): 52-63.